Skip to main content

Haley Pamela's Form 4 filing

Arcadia Biosciences, Inc. (RKDA) · filed Aug 3, 2022

Accession no.
0001209191-22-044269
Filed
Aug 3, 2022
Trade date
Aug 1, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $490. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Haley PamelaCIK 0001787373Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2022Common StockPPurchaseAcquired+700$0.70+$4905,088Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)